Cite
HARVARD Citation
Pu, H. et al. (2023). A Randomized, Single‐dose, Phase I Clinical Comparison of a Trastuzumab Biosimilar With a Reference Trastuzumab Formulation in Healthy Chinese Male Volunteers. Clinical pharmacology in drug development. 12 (2), pp. 181-189. [Online].